期刊文献+

AZ91D基CaP-CS-CNTs复合锌膜层制备及性能

Preparation and performance of AZ91D-Mg alloy based Zn^(2+) doped calcium phosphate/chitosan/CNTs compound coatings
下载PDF
导出
摘要 以AZ91D镁合金为基体,采用电泳沉积结合磷酸盐缓冲溶液浸渍的方法制备复合Zn^(2+)的AZ91D镁合金基钙磷(Calcium Phosphate,Ca P)/壳聚糖(Chitosans,CSs)/碳纳米管(Carbon Nano Tubes,CNTs)复合膜层,利用单因素的实验方法,对Zn^(2+)载入量进行优化,选择一种最佳的剂量,并对AZ91D镁合金基复合膜层的生物活性进行研究.结果表明,AZ91D镁合金基Ca P-CS-CNTs-Zn复合膜层(CCZ膜层)的最佳制备工艺为Zn(NO_3)_2的加入量为0.05 g,材料具有良好的生物活性,材料的抗菌性可以在植入材料后的14 d左右,持续发挥作用. AZ91D- Mg alloy based Zn(2+)doped calcium phosphate/chitosan/CNTs compound coatings was prepared with the electrophoresis deposit combined with buffered solution of phosphate impregnation in which Zn(2+)was loaded in the Ca P- CS- CNTs compound coatings. Single factor experimental method was used to optimize the loading quantity of Zn(2+)in order to choose the optimal dosage. Bioactivity of AZ91 D magnesium alloy matrix compound coatings was also studied. The result showed that the optimal dosage of Zn( NO_3)2was 0. 05 g for the best preparation technology for AZ91 D magnesium alloy matrix Ca P- CS- CNTs compound coatings. The materials possess good bioactivity and its antibacterial property was still active 14 days after it was implanted.
出处 《哈尔滨商业大学学报(自然科学版)》 CAS 2016年第2期165-169,共5页 Journal of Harbin University of Commerce:Natural Sciences Edition
基金 国家自然科学基金(51272058)
关键词 Zn2+膜层 AZ91D镁合金 复合膜层 生物活性 Zn2+ doped AZ91D magnesium composite film bioactivity
  • 相关文献

参考文献10

  • 1韩字洋,王铭,李小静.生物医用材料的功能化简介[c]//天津生物医学工程学会第三十四届学术年会,2014.26.
  • 2AL - ABDULLAT Y, TSUTSUMI S, NAKAJIMA N, et al. Sur- face modification of magnesium by NaHCO3 and corrosion behav- ior in Hank solution for new biomaterial applications [ J]. Ma- ter Trans. , 2001,42(8) : 1777 - 1780.
  • 3HAFERKAMP H, BOEHM R, HOLZKAMP U, et al. Alloy de- velopment processing and applications in magnesium lithium al- loys [J]. Materials Transactions. 2014, 2(7) : 1160 -1166.
  • 4MARK PS, ALEXIS MP, ]ERAWAL AH, et al. Magnesium and it alloys as orthopedic biomaterials: a review [ J ]. Bioma- terial, 2006, 27: 1728- 1734.
  • 5高家诚,乔丽英.镁基可降解硬组织生物材料的研究进展[J].功能材料,2008,39(5):705-708. 被引量:19
  • 6HAN H S, KIM Y Y, KIM Y C, et al. Bone formation within the vicinity of biodegradable magnesium alloy implant in a rat fe- mur model [J]. Metals and Materials International, 2012, 18 (2) : 243 -247.
  • 7李龙川,高家诚,王勇.医用镁合金的腐蚀行为与表面改性[J].材料导报,2003,17(10):29-32. 被引量:66
  • 8孟德营,刘金华,姜丽娜.羟基磷灰石/壳聚糖生物复合材料研究进展[J].山东轻工业学院学报(自然科学版),2009,23(1):33-37. 被引量:6
  • 9KOKUBO T, TAKADAMA H. How useful is SBF in predicting in vivo bone bioactivity [ J ]. Biomaterials, 2006, 27 ( 15 ) : 2907 - 2915.
  • 10OYANE A, KIM H M. Preparation and assessment of revised simulated body fluids [ J ]. Journal of Biomedical Materials Re- search Part A, 2003, 65A (2) : 188 -195.

二级参考文献70

共引文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部